Tether invests $200 million in Blackrock Neurotech, a top rival of Elon Musk’s Neuralink

Tether,
the
company
behind
the
largest
stablecoin
by
market
cap,
has
invested
$200
million
in
Blackrock
Neurotech,
one
of
the
major
competitors
of
Neuralink,
Elon
Musk’s
brain-chip
company.
With
this
move,
Tether
has
become
Blackrock
Neurotech’s
major
stakeholder.

According
to
a
press
release
published
today,
the
investment
was
made
through
Tether
Evo,
Tether’s
venture
division.
This
marks
a
significant
move
into
the
Brain-Computer
Interface
(BCI)
technology
sector.

Blackrock
Neurotech,
founded
in
2008,
is
at
the
forefront
of
BCI
technology,
developing
neural
implants
that
aid
individuals
with
paralysis
and
neurological
disorders.
The
company
is
known
for
its
MoveAgain
BCI
system
designed
for
home
use,
allowing
patients
to
control
devices
with
their
thoughts.

In
May
2021,
Blackrock
Neurotech
closed
a
$10
million
financing
round
led
by
Christian
Angermayer’s
re.Mind
Capital
with
participation
from
Peter
Thiel,
German
entrepreneur
Tim
Sievers,
and
Sorenson
Impact’s
University
Venture
Fund
II.

The
firm
also
achieved
a
historic
milestone
when
its
patient,
Nathan
Copeland,
used
a
BCI
to
fist
bump
former
President
Barack
Obama.

The
$200
million
investment
from
Tether
will
fund
the
commercialization
of
Blackrock
Neurotech’s
medical
solutions
and
support
its
R&D
efforts
to
maintain
its
position
as
a
leading
BCI
company.

Paolo
Ardoino,
CEO
of
Tether,
expressed
the
company’s
commitment
to
technologies
that
improve
the
quality
of
life
for
those
with
neurological
conditions
and
expand
the
applications
of
their
technology.

“Blackrock
Neurotech
is
just
the
beginning
of
our
journey
through
Tether
Evo
to
venture
into
projects
that
redefine
the
boundaries
of
what’s
possible
at
the
intersection
of
technological
innovation
and
human
potential.
Tether
has
long
believed
in
nurturing
emerging
technologies
that
have
transformative
capabilities,
and
the
Brain-Computer-Interfaces
of
Blackrock
Neurotech
have
the
potential
to
open
new
realms
of
communication,
rehabilitation,
and
cognitive
enhancement,”
said
Ardoino.

Florian
Solzbacher,
Co-Founder
of
Blackrock
Neurotech,
emphasized
the
importance
of
visionary
partners
in
advancing
healthcare
technologies.

“My
life’s
dream
has
been
to
help
and
restore
function
in
people
who
lost
it
and
to
advance
technologies
that
revolutionize
healthcare
and
the
world
around
us.
This
ambitious,
long-term
endeavor
requires
dedicated
and
visionary
partners.
With
its
commitment
to
seeking
out
and
nurturing
technology
that
will
help
many
people
and
push
mankind
forward,
we
couldn´t
dream
of
a
better
partner
than
Tether
to
bring
our
shared
vision
to
life,”
said
Solzbacher.

Tether’s
venture
in
Blackrock
Neurotech
is
part
of
its
broader
strategy
to
support
innovative
technologies
through

its
newly
launched
divisions,
including
Tether
Power,
Tether
Edu,
and
Tether
Data,
each
focusing
on
different
aspects
of
technological
advancement
and
human
potential.